January 19, 2017Open Access

Clinical assessment and train-of-four measurements in critically ill patients treated with recommended doses of cisatracurium or atracurium for neuromuscular blockade: a prospective descriptive study

PBPierre BoujuCentre Hospitalier de Bretagne Sud JTJean‐Marc TadiéInserm NBNicolas BarbarotUniversité de Tours

Key Points

Key points are not available for this paper at this time.

Abstract

The study provides data on clinical and TOF monitoring of neuromuscular blockade, which are widely divergent in ICU patients receiving recommended doses of benzylisoquinoliniums.

KI fragen

Bookmark

View Full Paper

Cite This Study

Bouju et al. (Thu,) studied this question.

synapsesocial.com/papers/69d8fe3bb305d713c2bed902 https://doi.org/https://doi.org/10.1186/s13613-017-0234-0

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Controlled Sedation with Alphaxalone-Alphadolone1974 · 2,916 citations
2Monitoring Sedation Status Over Time in ICU Patients2003 · 1,721 citations
3A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study1993 · 6,370 citations
4The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.1996 · 45 citations
5Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome2010 · 2,440 citations

KI fragen

Bookmark

View Full Paper